Format

Send to

Choose Destination
Clin Adv Hematol Oncol. 2015 May;13(5):282-4.

Combining inhibitors of ALK and ROS1 with other agents for the treatment of non-small cell lung cancer.

Author information

1
Department of Medicine, Harvard Medical School, Boston, Massachusetts.
PMID:
26352769
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center